Patent · US Active

Modified interferon beta polypeptides and their uses

US8329869B2 · kind B2 · utility

21Cited by

5References

6Claims

0Family size

Assignee

Ambrx, Inc. · US

Inventors

Vadim Kraynov · San Diego, US
Nick Knudsen · San Diego, US
Anna-Maria A. Hays Putnam · San Diego, US
Denise Krawitz · San Diego, US
Jason Pinkstaff · Novato, US
Heather Myler · Carlsbad, US

Key dates

Filing date	Jan 6, 2012
Grant date	Dec 11, 2012
Priority date	—
Expiry date	Jan 6, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified interferon beta polypeptides and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.